Wednesday , October 18 2017
Home / Managing Editor, Diabetes in Control (page 35)

Managing Editor, Diabetes in Control

Managing Editor, Diabetes in Control

The Value of the Nitric Oxide Pathway and its Importance in African-American Patients with Heart Failure

Talking to Patients

Studies in heart failure and hypertension have shown that people who identify themselves as black may have a less active renin-angiotensin system and a lower bioavailability of nitric oxide. The A-HeFT study was conducted to determine if a fixed dose of isosorbide dinitrate (ISDN) and hydralazine would provide additional benefit in black patients with heart failure.

Read More »

Editor’s Note – DCMS-258


I was reading this week’s Clinical Gem about the use of diuretics for reducing heart failure and blood pressure values. There was a mention of the differences in responses among certain ethnic groups and the difficulty that we often have with African-American patients. There was a lot of focus on ...

Read More »

Dragon Dictation


Dragon Dictation is an easy-to-use voice recognition application powered by Dragon® NaturallySpeaking® that allows you to easily speak and instantly see your text or email messages. In fact, it’s up to five (5) times faster than typing on the keyboard. Features: Voice-to-text transcriptions that may be sent as SMS, Email, ...

Read More »

Test Your Knowledge Question #798

Test Your Knowledge

A 43-year old patient with a 2-year history of type 2 diabetes presents to your office for a follow-up visit. She is a highly motivated patient and doesn’t have any significant co-morbidities, so together, you have set a target A1C= 6.5%. Her current medications are metformin and sulfonylurea. Despite her good efforts, her current A1C is 7.3%. You would like to add a third agent to her regimen, however she is concerned about any additional weight gain as she has gained a few pounds since starting the sulfonylurea. Which drug class would you add to minimize any additional weight gain? A. Basal insulin B. GLP-1 agonist C. Thiazolidine D. DPP-4 Inhibitor Follow link to take the test!

Read More »

Imperium: World’s First Instant Insulin Patch


Unilife Corporation has launched the world’s first instant insulin patch, Imperium. Imperium is a prefilled, preassembled, multi-day wearable insulin pump for continuous subcutaneous insulin infusion and on-demand bolus delivery through the push of a button. It is equipped with Bluetooth connectivity to wirelessly connect with smartphone apps for patient reminders ...

Read More »

Smart Blood Glucose Meter to Help Diabetes Patients


Patients with diabetes have to monitor their blood glucose at home until the next doctor’s appointment. Smart blood glucose meter provides patients with easy access to certified diabetes educator and avoid future diabetes complications, according to Jodi Pulizzi, RN, BSN, CDE, CHC, director of clinical services for Livongo Health, based ...

Read More »